Characteristics of the Novel Potassium-Competitive Acid Blocker Vonoprazan Fumarate (TAK-438)
Crossref DOI link: https://doi.org/10.1007/s12325-016-0345-2
Published Online: 2016-06-10
Published Print: 2016-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Otake, Kazuyoshi
Sakurai, Yuuichi
Nishida, Haruyuki
Fukui, Hideo
Tagawa, Yoshihiko
Yamasaki, Hitomi
Karashima, Masatoshi
Otsuka, Keiichi
Inatomi, Nobuhiro
Funding for this research was provided by:
Takeda Pharmaceutical Company
License valid from 2016-06-10